Studies how genes and surroundings may play a part in blood and lymph cancers
Studies families to learn how genes and exposures may contribute to blood and lymph cancers.
Key facts
- Who runs it
- Mayo Clinic
- Where
- Rochester, United StatesSee the site
- Trial code
- Registry title
- Family Study of Lymphoproliferative Disorders
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- 1 Apr 2004
- Expected to end
- 31 Dec 2029
- Type of study
- Observational
- Record updated
- 2 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for families with at least 2 living blood relatives who have a lymphoproliferative disorder, such as lymphoma, chronic lymphocytic leukemia or multiple myeloma.
- Age
- 18 Years to 100 Years
- Sex
- All sexes can join.
- Disease stage
- Lymphoproliferative disorder (blood and lymph node cancers); no stage is given.
The registry criteria, word for word
Show the criterionShow less
Other criteria
- At least 2 living, blood related relatives, affected with a lymphoproliferative disorder
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in United States
- Mayo ClinicRochester, United StatesContact: Clinical Trials Referral OfficeTaking people
About the trial
What the trial wants to find out
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Genetic Epidemiology of Lymphoproliferative Disorders
- Plain-language title
- Studies how genes and surroundings may play a part in blood and lymph cancersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT00626496, who can take part
- Record updated
- 2 November 2026